{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:12:50Z","timestamp":1759961570229},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":502,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"Japanese Ministry of Health, Labor, and Welfare"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.neuropharm.2011.12.007","type":"journal-article","created":{"date-parts":[[2011,12,16]],"date-time":"2011-12-16T16:36:26Z","timestamp":1324053386000},"page":"1841-1847","source":"Crossref","is-referenced-by-count":7,"title":["Role of PGE-type receptor 4 in auditory function and noise-induced hearing loss in mice"],"prefix":"10.1016","volume":"62","author":[{"given":"Kiyomi","family":"Hamaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Furuyashiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuh","family":"Narumiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2011.12.007_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.brainres.2005.10.068","article-title":"Prostaglandin EP4 receptor agonist protects against acute neurotoxicity","volume":"1066","author":"Ahmad","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.prostaglandins.2009.04.003","article-title":"Emerging roles of PGE2 receptors in models of neurological disease","volume":"91","author":"Andreasson","year":"2010","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1189\/jlb.1004569","article-title":"PGE2 confers survivin-dependent apoptosis resistance in human monocyte-derived dendritic cells","volume":"78","author":"Baratelli","year":"2005","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib4","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1158\/0008-5472.CAN-06-3617","article-title":"Cyclooxygenase-2 inhibits UVB-induced apoptosis in mouse skin by activating the prostaglandin E2 receptors, EP2 and EP4","volume":"67","author":"Chun","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib5","doi-asserted-by":"crossref","first-page":"12233","DOI":"10.1073\/pnas.0915112107","article-title":"Dual roles of PGE2-EP4 signaling in mouse experimental autoimmune encephalomyelitis","volume":"107","author":"Esaki","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2011.12.007_bib6","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.12.007_bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1471-4906(01)02154-8","article-title":"Prostaglandins as modulators of immunity","volume":"23","author":"Harris","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.neuroscience.2009.03.014","article-title":"Prostaglandin E receptor subtype EP4 agonist protects cochleae against noise-induced trauma","volume":"160","author":"Hori","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2011.12.007_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2202-11-35","article-title":"Role of prostaglandin E receptor subtypes EP2 and EP4 in autocrine and paracrine functions of vascular endothelial growth factor in the inner ear","volume":"11","author":"Hori","year":"2010","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib10","doi-asserted-by":"crossref","first-page":"12752","DOI":"10.1074\/jbc.M212097200","article-title":"Prostaglandin E2 protects gastric mucosal cells from apoptosis via EP2 and EP4 receptor activation","volume":"278","author":"Hoshino","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1172\/JCI0214459","article-title":"The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut","volume":"109","author":"Kabashima","year":"2002","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10162-008-0147-6","article-title":"A\u00a0mouse model for degeneration of the spiral ligament","volume":"10","author":"Kada","year":"2009","journal-title":"J.\u00a0Assoc. Res. Otolaryngol."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0090-6980(88)90085-8","article-title":"Prostaglandin synthesis by the cochlea","volume":"35","author":"Kawata","year":"1988","journal-title":"Prostaglandins"},{"key":"10.1016\/j.neuropharm.2011.12.007_bib14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.biocel.2009.09.015","article-title":"Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances","volume":"42","author":"Legler","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neulet.2008.04.054","article-title":"Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia","volume":"438","author":"Li","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib16","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1634\/stemcells.2006-0505","article-title":"Cyclooxygenase-2-derived prostaglandin e2 protects mouse embryonic stem cells from apoptosis","volume":"25","author":"Liou","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.neuropharm.2011.12.007_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.heares.2011.01.015","article-title":"Roles of prostaglandin E2 in the cochlea","volume":"276","author":"Nakagawa","year":"2011","journal-title":"Hear. Res."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0165-0173(03)00189-9","article-title":"Disorders of cochlear blood flow","volume":"43","author":"Nakashima","year":"2003","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2183\/pjab.83.296","article-title":"Physiology and pathophysiology of prostanoid receptors","volume":"83","author":"Narumiya","year":"2007","journal-title":"Proc. Jpn. Acad. Ser. B."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/36342","article-title":"The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth","volume":"390","author":"Nguyen","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.12.007_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0378-5955(00)00081-2","article-title":"Noise damage in the C57BL\/CBA mouse cochlea","volume":"145","author":"Ou","year":"2000","journal-title":"Hear. Res."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0378-5955(99)00059-3","article-title":"Distortion product otoacoustic emissions in the CBA\/J mouse model of presbycusis","volume":"134","author":"Parham","year":"1999","journal-title":"Hear. Res."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib23","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1523\/JNEUROSCI.3955-10.2011","article-title":"A\u00a0corticosteroid-responsive transcription factor, promyelocytic leukemia zinc finger protein, mediates protection of the cochlea from acoustic trauma","volume":"31","author":"Peppi","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.heares.2006.02.004","article-title":"Vascular endothelial growth factor (VEGF) expression in noise-induced hearing loss","volume":"214","author":"Picciotti","year":"2006","journal-title":"Hear. Res."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.heares.2010.10.008","article-title":"Ablation of mixed lineage kinase 3 (Mlk3) does not inhibit ototoxicity induced by acoustic trauma or aminoglycoside exposure","volume":"270","author":"Polesskaya","year":"2010","journal-title":"Hear. Res."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1749-6632.1999.tb08646.x","article-title":"Excitotoxicity, synaptic repair, and functional recovery in the mammalian cochlea: a review of recent findings","volume":"884","author":"Pujol","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib27","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s004050050195","article-title":"Effects of leukotrienes and prostaglandins on cochlear blood flow in the chinchilla","volume":"256","author":"Rhee","year":"1999","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/bbrc.1998.8461","article-title":"Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice","volume":"246","author":"Segi","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00405-006-0154-3","article-title":"Fast alterations of vascular endothelial growth factor (VEGF) expression and that of its receptors (Flt-1, Flk-1 and Neuropilin) in the cochlea of guinea pigs after moderate noise exposure","volume":"264","author":"Selivanova","year":"2007","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib30","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.4049\/jimmunol.0903487","article-title":"The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity","volume":"184","author":"Shi","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/pr.56.3.3","article-title":"Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition","volume":"56","author":"Simmons","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: structural, cellular, and molecular biology","volume":"69","author":"Smith","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.heares.2004.04.018","article-title":"Localization of prostanoid receptors and cyclo-oxygenase enzymes in guinea pig and human cochlea","volume":"197","author":"Stjernschantz","year":"2004","journal-title":"Hear. Res."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib34","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1074\/jbc.R600038200","article-title":"Prostaglandin E receptors","volume":"282","author":"Sugimoto","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib35","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1210\/endo.141.4.7405","article-title":"The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs","volume":"141","author":"Suzawa","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2011.12.007_bib36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.heares.2010.04.013","article-title":"The p75 neurotrophin receptor protects primary auditory neurons against acoustic trauma in mice","volume":"268","author":"Tan","year":"2010","journal-title":"Hear. Res."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1152\/jn.1959.22.2.149","article-title":"Stria vascularis as source of endocochlear potential","volume":"22","author":"Tasaki","year":"1959","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib38","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/00016480500316803","article-title":"Response of cochlear blood flow to prostaglandin E1 applied topically to the round window","volume":"126","author":"Tominaga","year":"2006","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib39","first-page":"12","article-title":"Hearing in laboratory animals: strain differences and nonauditory effects of noise","volume":"55","author":"Turner","year":"2005","journal-title":"Comp. Med."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib40","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/000348949009900615","article-title":"Effect of arachidonic acid on the inner ear blood flow measured with a laser Doppler flowmeter","volume":"99","author":"Umemura","year":"1990","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib41","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.trsl.2010.08.002","article-title":"Limaprost reduces motor disturbances by increasing the production of insulin-like growth factor I in rats subjected to spinal cord injury","volume":"156","author":"Umemura","year":"2010","journal-title":"Transl. Res."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.heares.2004.04.016","article-title":"The guide to plotting a cochleogram","volume":"197","author":"Viberg","year":"2004","journal-title":"Hear. Res."},{"key":"10.1016\/j.neuropharm.2011.12.007_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0378-5955(99)00210-5","article-title":"Acoustic injury in mice: 129\/SvEv is exceptionally resistant to noise-induced hearing loss","volume":"141","author":"Yoshida","year":"2000","journal-title":"Hear. Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811005119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811005119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T01:08:49Z","timestamp":1561079329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390811005119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0028390811005119"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.12.007","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}